
### [MONDO:0018299](http://purl.obolibrary.org/obo/MONDO_0018299)
**Label:** sphingolipidosis with epilepsy

**Subclasses:** [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0009591](http://purl.obolibrary.org/obo/MONDO_0009591) (metachromatic leukodystrophy, juvenile form), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499) (Krabbe disease), [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719) (gangliosidosis), [MONDO:0018868](http://purl.obolibrary.org/obo/MONDO_0018868) (metachromatic leukodystrophy), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), 

**Corr. equiv. classes:** [OMIM:272800](http://purl.obolibrary.org/obo/OMIM_272800), [Orphanet:487](http://www.orpha.net/ORDO/Orphanet_487), [Orphanet:354](http://www.orpha.net/ORDO/Orphanet_354), [Orphanet:309263](http://www.orpha.net/ORDO/Orphanet_309263), [Orphanet:309152](http://www.orpha.net/ORDO/Orphanet_309152), [Orphanet:309144](http://www.orpha.net/ORDO/Orphanet_309144), [OMIM:268800](http://purl.obolibrary.org/obo/OMIM_268800), [OMIM:245200](http://purl.obolibrary.org/obo/OMIM_245200), [Orphanet:845](http://www.orpha.net/ORDO/Orphanet_845), [Orphanet:646](http://www.orpha.net/ORDO/Orphanet_646), [OMIM:250100](http://purl.obolibrary.org/obo/OMIM_250100), [Orphanet:796](http://www.orpha.net/ORDO/Orphanet_796), [Orphanet:512](http://www.orpha.net/ORDO/Orphanet_512), 

**Class expressions from DL-Learner:**

- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0010766](http://purl.obolibrary.org/obo/HP_0010766) (Ectopic calcification))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0005561](http://purl.obolibrary.org/obo/HP_0005561) (Abnormality of bone marrow cell morphology))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0004332](http://purl.obolibrary.org/obo/HP_0004332) (Abnormality of lymphocytes))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues))) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0010969](http://purl.obolibrary.org/obo/HP_0010969) (Abnormality of glycolipid metabolism) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0010968](http://purl.obolibrary.org/obo/HP_0010968) (Abnormality of liposaccharide metabolism) 65.38%
- [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0004343](http://purl.obolibrary.org/obo/HP_0004343) (Abnormality of glycosphingolipid metabolism) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0000929](http://purl.obolibrary.org/obo/HP_0000929) (Abnormality of the skull) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%


